VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
CERTCertara, Inc.
$5.54$862M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

CERT logoCertara, Inc.(CERT)Earnings, Financials & Key Ratios

CERT•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryHealthcare ITSub-IndustryLife Sciences and Precision Medicine Software
AboutCertara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.Show more
  • Revenue$419M+8.7%
  • EBITDA$78M+17.0%
  • Net Income-$2M+86.8%
  • EPS (Diluted)-0.01+86.7%
  • Gross Margin61.53%+2.8%
  • EBITDA Margin18.52%+7.6%
  • Operating Margin5.02%+1216.5%
  • Net Margin-0.38%+87.8%
  • ROE-0.15%+86.9%

CERT Key Insights

Certara, Inc. (CERT) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Strong 5Y profit CAGR of 49.7%
  • ✓FCF machine: 22.6% free cash flow margin
  • ✓Strong 5Y sales CAGR of 11.5%
  • ✓Trading at only 0.8x book value

✗Weaknesses

  • ✗Weak momentum: RS Rating 17 (bottom 17%)
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when CERT posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CERT Price & Volume

Certara, Inc. (CERT) stock price & volume — 10-year historical chart

Loading chart...

CERT Growth Metrics

Certara, Inc. (CERT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years11.45%
3 Years7.66%
TTM6.4%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-475.28%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-505.06%

Return on Capital

10 Years0.14%
5 Years0.37%
3 Years-0.48%
Last Year1.48%

CERT Recent Earnings

Certara, Inc. (CERT) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
May 11, 2026
Metric
Actual
Est
EPS
$0.09-18.2%
$0.11
Rev
$107M+0.7%
$106M
Q1 2026
Feb 26, 2026
Metric
Actual
Est
EPS
$0.09-18.2%
$0.11
Rev
$104M+0.5%
$103M
Q4 2025
Nov 6, 2025
Metric
Actual
Est
EPS
$0.14+27.3%
$0.11
Rev
$105M+1.3%
$103M
Q3 2025
Aug 6, 2025
Metric
Actual
Est
EPS
$0.07-30.0%
$0.10
Rev
$105M+0.5%
$104M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 11, 2026
$0.09vs $0.11-18.2%
$107Mvs $106M+0.7%
Q1 2026Feb 26, 2026
$0.09vs $0.11-18.2%
$104Mvs $103M+0.5%
Q4 2025Nov 6, 2025
$0.14vs $0.11+27.3%
$105Mvs $103M+1.3%
Q3 2025Aug 6, 2025
$0.07vs $0.10-30.0%
$105Mvs $104M+0.5%
Based on last 12 quarters of dataView full earnings history →

CERT Peer Comparison

Certara, Inc. (CERT) competitors in Life Sciences and Precision Medicine Software — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
MEDP logoMEDPMedpace Holdings, Inc.Direct Competitor13.14B460.2030.1219.97%17.19%120.89%0.55
IQV logoIQVIQVIA Holdings Inc.Direct Competitor28.47B167.7721.405.87%8.33%22.11%2.44
CRL logoCRLCharles River Laboratories International, Inc.Direct Competitor8.91B185.00-63.57-0.85%-4.59%-5.66%0.95
VEEV logoVEEVVeeva Systems Inc.Direct Competitor24.9B153.3028.1816.34%28.37%13.36%0.01
SLP logoSLPSimulations Plus, Inc.Product Competitor367.47M18.24-5.6613.09%-81.66%-50.54%0.00
SDGR logoSDGRSchrödinger, Inc.Product Competitor1.18B15.76-11.1823.29%-40.6%-30.85%0.30
RXRX logoRXRXRecursion Pharmaceuticals, Inc.Product Competitor1.44B3.23-2.2426.92%-8.44%-54.32%0.07
EXLS logoEXLSExlService Holdings, Inc.Product Competitor4.06B25.9316.8413.56%11.66%27.16%0.44

Compare CERT vs Peers

Certara, Inc. (CERT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs MEDP

Most directly comparable listed peer for CERT.

Scale Benchmark

vs LLY

Larger-name benchmark to compare CERT against a more recognizable public peer.

Peer Set

Compare Top 5

vs MEDP, IQV, CRL, VEEV

CERT Income Statement

Certara, Inc. (CERT) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
163.72M208.51M243.53M286.1M335.64M354.34M385.15M418.84M419.75M
Revenue Growth %
-27.36%16.79%17.48%17.32%5.57%8.7%8.75%6.4%
Cost of Goods Sold
71.04M79.77M100.77M111.62M132.58M141.02M154.52M161.13M175.81M
COGS % of Revenue
43.39%38.26%41.38%39.01%39.5%39.8%40.12%38.47%-
Gross Profit
92.68M▲ 0%
128.74M▲ 38.9%
142.76M▲ 10.9%
174.49M▲ 22.2%
203.07M▲ 16.4%
213.31M▲ 5.0%
230.63M▲ 8.1%
257.71M▲ 11.7%
243.94M▲ 0%
Gross Margin %
56.61%61.74%58.62%60.99%60.5%60.2%59.88%61.53%58.12%
Gross Profit Growth %
-38.92%10.89%22.22%16.38%5.05%8.12%11.74%-
Operating Expenses
97.33M109.13M167.19M160.91M170.55M254.09M232.36M236.7M226.6M
OpEx % of Revenue
59.45%52.34%68.65%56.24%50.81%71.71%60.33%56.51%-
Selling, General & Admin
52.81M58.66M107.68M99.68M99.18M127.41M120.97M139.1M149.46M
SG&A % of Revenue
32.26%28.13%44.22%34.84%29.55%35.96%31.41%33.21%-
Research & Development
10.48M11.63M19.64M20.38M28.2M34.17M37.1M41.04M42.8M
R&D % of Revenue
6.4%5.58%8.07%7.12%8.4%9.64%9.63%9.8%-
Other Operating Expenses
-107K38.84M39.86M40.85M43.16M92.51M74.29M56.56M2M
Operating Income
-4.65M▲ 0%
19.61M▲ 521.6%
-24.42M▼ 224.5%
13.58M▲ 155.6%
32.52M▲ 139.5%
-40.77M▼ 225.4%
-1.73M▲ 95.8%
21.02M▲ 1314.1%
17.34M▲ 0%
Operating Margin %
-2.84%9.41%-10.03%4.75%9.69%-11.51%-0.45%5.02%4.13%
Operating Income Growth %
-521.6%-224.51%155.61%139.49%-225.38%95.75%1314.1%-
EBITDA
32.36M61.17M18.33M58.69M84.99M15.3M66.3M77.57M74.37M
EBITDA Margin %
19.77%29.34%7.53%20.51%25.32%4.32%17.21%18.52%17.72%
EBITDA Growth %
-89.04%-70.03%220.15%44.8%-82%333.43%17%21.83%
D&A (Non-Cash Add-back)
37.01M41.56M42.75M45.12M52.47M56.07M68.03M56.56M57.03M
EBIT
-4.76M18.85M-24.89M13.46M36.53M-32.23M4.34M27.35M51.19M
Net Interest Income
-27.8M-28M-25.3M-16.84M-17.77M-22.92M-21.52M-19.74M-49.11M
Interest Income
000000000
Interest Expense
27.8M28M25.3M16.84M17.77M22.92M21.52M19.74M49.11M
Other Income/Expense
-27.91M-28.76M-25.76M-16.95M-13.77M-14.37M-15.45M-13.4M-22.21M
Pretax Income
-32.56M▲ 0%
-9.15M▲ 71.9%
-50.18M▼ 448.4%
-3.38M▲ 93.3%
18.75M▲ 655.7%
-55.14M▼ 394.0%
-17.18M▲ 68.8%
7.62M▲ 144.3%
-4.87M▲ 0%
Pretax Margin %
-19.89%-4.39%-20.61%-1.18%5.59%-15.56%-4.46%1.82%-1.16%
Income Tax
697K-225K-784K9.89M4.02M214K-5.13M9.21M10.23M
Effective Tax Rate %
-2.14%2.46%1.56%-293.07%21.46%-0.39%29.87%120.94%-210.15%
Net Income
-33.26M▲ 0%
-8.93M▲ 73.2%
-49.4M▼ 453.4%
-13.27M▲ 73.1%
14.73M▲ 211.0%
-55.36M▼ 475.8%
-12.05M▲ 78.2%
-1.59M▲ 86.8%
-15.1M▲ 0%
Net Margin %
-20.31%-4.28%-20.28%-4.64%4.39%-15.62%-3.13%-0.38%-3.6%
Net Income Growth %
-73.16%-453.41%73.14%211.04%-475.79%78.23%86.76%-475.28%
Net Income (Continuing)
-33.26M-8.93M-49.4M-13.27M14.73M-55.36M-12.05M-1.59M-15.1M
Discontinued Operations
000000000
Minority Interest
000000000
EPS (Diluted)
-0.25▲ 0%
-0.06▲ 77.3%
-0.32▼ 464.4%
-0.09▲ 72.3%
0.09▲ 204.4%
-0.35▼ 478.8%
-0.08▲ 78.5%
-0.01▲ 86.7%
-0.10▲ 0%
EPS Growth %
-77.32%-464.37%72.34%204.41%-478.79%78.54%86.68%-505.06%
EPS (Basic)
-0.25-0.06-0.32-0.090.09-0.35-0.08-0.01-
Diluted Shares Outstanding
132.41M157.34M152.98M149.84M159.35M158.94M160.39M160.39M157.75M
Basic Shares Outstanding
132.41M157.34M152.98M149.84M156.88M158.94M160.39M160.39M157.75M
Dividend Payout Ratio
---------

CERT Balance Sheet

Certara, Inc. (CERT) balance sheet — assets, liabilities & shareholders' equity

MetricDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
68.93M87.52M346.58M274.73M342.25M340.2M310.85M315.12M270.56M
Cash & Short-Term Investments
11.68M29.26M271.38M185.8M236.59M234.95M179.18M189.39M149.48M
Cash Only
11.68M29.26M271.38M185.8M236.59M234.95M179.18M189.39M149.48M
Short-Term Investments
000000000
Accounts Receivable
49.88M52.36M64.8M78.31M88.81M93.26M119.08M103.53M96.07M
Days Sales Outstanding
111.2191.6597.1299.996.5796.06112.8590.2287.91
Inventory
5.53M00000000
Days Inventory Outstanding
28.43--------
Other Current Assets
3.32M2.14M3.03M1.65M8.47M5.63M4.27M22.2M25M
Total Non-Current Assets
982.56M949.55M922.82M1.24B1.23B1.22B1.26B1.24B1.23B
Property, Plant & Equipment
5.4M4.62M3.87M15.57M16.83M12.27M16.01M13.79M13.07M
Fixed Asset Turnover
30.31x45.10x62.90x18.38x19.95x28.87x24.06x30.37x30.12x
Goodwill
514.27M515M518.59M703.37M717.74M716.33M757.04M773.31M770.76M
Intangible Assets
459.62M428M396.44M511.82M486.78M487.04M485.21M447.48M433.25M
Long-Term Investments
1.16M00000000
Other Non-Current Assets
1.26M1.1M1.16M2.17M5.62M3.05M2.03M1.64M1.6M
Total Assets
1.05B▲ 0%
1.04B▼ 1.4%
1.27B▲ 22.4%
1.51B▲ 19.1%
1.57B▲ 4.0%
1.56B▼ 0.6%
1.58B▲ 0.8%
1.56B▼ 1.2%
1.5B▲ 0%
Asset Turnover
0.16x0.20x0.19x0.19x0.21x0.23x0.24x0.27x0.27x
Asset Growth %
--1.37%22.4%19.09%4.05%-0.62%0.77%-1.18%-5.29%
Total Current Liabilities
65.45M63M75.34M92.22M103.16M130.02M146.09M153.38M144.12M
Accounts Payable
4.91M4.92M6.39M7.46M7.53M5.17M3.5M3.43M3.69M
Days Payables Outstanding
25.2222.523.1624.3920.7413.388.277.768.33
Short-Term Debt
3.15M4.21M4.68M3.02M3.02M3.02M3M2.96M2.96M
Deferred Revenue (Current)
37.52M26.24M30.66M45.5M52.21M60.68M77.83M75.41M287.15M
Other Current Liabilities
12.58M8.35M29.45M26.95M31.01M49.51M53.08M71.58M60.99M
Current Ratio
1.05x1.39x4.60x2.98x3.32x2.62x2.13x2.05x1.88x
Quick Ratio
0.97x1.39x4.60x2.98x3.32x2.62x2.13x2.05x1.88x
Cash Conversion Cycle
114.42-------79.58
Total Non-Current Liabilities
493.27M482.02M371.92M377.66M390.1M386.28M370.36M340.4M339.2M
Long-Term Debt
404.8M397.12M294.1M291.75M289.99M288.22M292.43M8.44M7.79M
Capital Lease Obligations
48K0318K8.28M10.13M6.96M11.17M018.33M
Deferred Tax Liabilities
85.67M82.16M75.89M76.1M67.35M50.83M40.42M34.37M138.32M
Other Non-Current Liabilities
01.6M1.07M019.81M39.21M25.3M297.6M296.67M
Total Liabilities
558.72M545.02M447.27M469.88M493.26M516.3M516.45M493.79M483.32M
Total Debt
408.28M401.38M299.37M308.38M308.13M302.57M311.9M11.4M10.75M
Net Debt
396.6M372.12M27.99M122.58M71.55M67.62M132.71M-177.99M-138.73M
Debt / Equity
0.83x0.82x0.36x0.30x0.29x0.29x0.29x0.01x0.01x
Debt / EBITDA
12.62x6.56x16.33x5.25x3.63x19.78x4.70x0.15x0.14x
Net Debt / EBITDA
12.26x6.08x1.53x2.09x0.84x4.42x2.00x-2.29x-1.87x
Interest Coverage
-0.17x0.67x-0.98x0.80x2.06x-1.41x0.20x1.39x1.04x
Total Equity
492.77M▲ 0%
492.05M▼ 0.1%
822.13M▲ 67.1%
1.04B▲ 26.7%
1.08B▲ 3.6%
1.05B▼ 3.0%
1.06B▲ 1.1%
1.06B▲ 0.4%
1.02B▲ 0%
Equity Growth %
--0.15%67.08%26.73%3.63%-3.04%1.13%0.39%-2.12%
Book Value per Share
3.723.135.376.956.786.596.606.636.45
Total Shareholders' Equity
492.77M492.05M822.13M1.04B1.08B1.05B1.06B1.06B1.02B
Common Stock
1.32M1.32M1.53M1.6M1.6M1.6M1.62M1.64M1.64M
Retained Earnings
-14.43M-12.94M-62.34M-75.6M-60.87M-116.23M-128.28M-129.88M-138.64M
Treasury Stock
000-38K-3M-9.4M-18.18M00
Accumulated OCI
-1.65M-5.5M-1.59M-3.93M-8.23M-7.59M-13.42M2.04M-1.87M
Minority Interest
000000000

CERT Cash Flow Statement

Certara, Inc. (CERT) cash flow — operating, investing & free cash flow history

MetricDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
11.59M38.02M44.81M60.39M92.54M82.75M80.47M96.33M90.67M
Operating CF Margin %
7.08%18.24%18.4%21.11%27.57%23.35%20.89%23%-
Operating CF Growth %
-228.03%17.84%34.76%53.25%-10.58%-2.77%19.71%97.79%
Net Income
-33.26M-8.93M-49.4M-13.27M14.73M-55.36M-12.05M-1.59M-15.1M
Depreciation & Amortization
37.01M41.56M42.75M45.12M54.01M57.6M68.03M75.16M56.53M
Stock-Based Compensation
1.71M1.69M64.51M29.48M30.35M28.3M34.77M33.08M25.14M
Deferred Taxes
-3.55M-6.7M-7.83M-1.18M00-12.7M-8.32M-23.86M
Other Non-Cash Items
1.36M1.66M1.49M3.16M8.34M51.35M10.59M-1.89M27.41M
Working Capital Changes
8.32M8.74M-6.71M-2.92M-14.88M863K-8.18M-115K14.65M
Change in Receivables
-2.03M-1.52M-3.93M-10.07M-15.01M152K-16.23M428K-1.41M
Change in Inventory
-2.61M00000000
Change in Payables
-6.36M10.03M2.38M000-4.76M4.4M10.67M
Cash from Investing
-73.91M-9.52M-8.61M-269.92M-27.84M-79.55M-112.37M-26.56M-27.56M
Capital Expenditures
-11.48M-2.11M-7.94M-8.9M-1.43M-1.78M-1.63M-1.76M4.39M
CapEx % of Revenue
7.02%1.01%3.26%3.11%0.43%0.5%0.42%0.42%1.04%
Acquisitions
-62.42M0-675K-261.02M-15.31M-64.23M-91.33M-13.23M-16.23M
Investments
---------
Other Investing
-6.73M-7.41M00-11.1M-13.55M-19.42M-11.57M-15.72M
Cash from Financing
57.3M-8.49M208.21M123.39M-7.36M-9.45M-21.01M-63.99M-93.73M
Debt Issued (Net)
66.02M-8.44M-104.36M-3.88M-3.31M-3.04M4.05M-2.99M9K
Equity Issued (Net)
10K-53K315.47M133.35M-2.96M-6.4M-8.69M-42.61M-82.67M
Dividends Paid
000000000
Share Repurchases
-1.1M-703K-1.08M0-2.96M-6.4M-8.69M-42.61M-82.67M
Other Financing
-8.73M0-2.9M-6.08M-1.09M0-16.37M-18.39M-11.07M
Net Change in Cash
-6.35M▲ 0%
17.57M▲ 376.6%
243.53M▲ 1285.7%
-86.67M▼ 135.6%
53.06M▲ 161.2%
-4.74M▼ 108.9%
-55.77M▼ 1077.3%
10.21M▲ 118.3%
-29.6M▲ 0%
Free Cash Flow
107K▲ 0%
28.51M▲ 26543.0%
36.87M▲ 29.3%
51.49M▲ 39.6%
91.11M▲ 77.0%
80.98M▼ 11.1%
78.84M▼ 2.6%
94.56M▲ 19.9%
88.88M▲ 0%
FCF Margin %
0.07%13.67%15.14%18%27.15%22.85%20.47%22.58%21.17%
FCF Growth %
-26542.99%29.34%39.63%76.97%-11.12%-2.64%19.94%9.29%
FCF per Share
0.000.180.240.340.570.510.490.590.56
FCF Conversion (FCF/Net Income)
-0.35x-4.26x-0.91x-4.55x6.28x-1.49x-6.68x-60.39x-5.89x
Interest Paid
25.71M26.43M27.61M14.17M17.27M19.09M22.74M0-4.65M
Taxes Paid
3.17M4.11M12.28M8.6M0014.66M0-688K

CERT Key Ratios

Certara, Inc. (CERT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2019202020212022202320242025TTM
Return on Equity (ROE)
-1.81%-7.52%-1.42%1.39%-5.21%-1.14%-0.15%-1.43%
Return on Invested Capital (ROIC)
1.68%-2.14%1.01%2.11%-2.7%-0.11%1.52%1.25%
Gross Margin
61.74%58.62%60.99%60.5%60.2%59.88%61.53%58.12%
Net Margin
-4.28%-20.28%-4.64%4.39%-15.62%-3.13%-0.38%-3.6%
Debt / Equity
0.82x0.36x0.30x0.29x0.29x0.29x0.01x0.01x
Interest Coverage
0.67x-0.98x0.80x2.06x-1.41x0.20x1.39x1.04x
FCF Conversion
-4.26x-0.91x-4.55x6.28x-1.49x-6.68x-60.39x-5.89x
Revenue Growth
27.36%16.79%17.48%17.32%5.57%8.7%8.75%6.4%
Related:CERT Dividend History·CERT Revenue History·CERT Price History·CERT P/E History·CERT Financial Ratios·CERT Institutional Holders

CERT SEC Filings & Documents

Certara, Inc. (CERT) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 15, 2026·SEC

Material company update

May 11, 2026·SEC

Material company update

Apr 22, 2026·SEC

10-K Annual Reports

4
FY 2026

Feb 26, 2026·SEC

FY 2025

Feb 26, 2025·SEC

FY 2024

Feb 29, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 11, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 6, 2025·SEC

CERT Frequently Asked Questions

Certara, Inc. (CERT) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Certara, Inc. (CERT) reported $419.7M in revenue for fiscal year 2025. This represents a 156% increase from $163.7M in 2018.

Certara, Inc. (CERT) grew revenue by 8.7% over the past year. This is steady growth.

Certara, Inc. (CERT) reported a net loss of $15.1M for fiscal year 2025.

Dividend & Returns

Certara, Inc. (CERT) has a return on equity (ROE) of -0.2%. Negative ROE indicates the company is unprofitable.

Certara, Inc. (CERT) generated $88.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in CERT back in 2018?

Total return calculator · dividends reinvested · 8+ years of data

See returns →

How much would $100/month in CERT be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →